Renalytix Plc Share Price Börse Stuttgart
Equities
2O9
GB00BYWL4Y04
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 EUR | 0.00% |
|
+6.15% | +12.43% |
14/06 | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
14/06 | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
Sales 2024 * | 2.5M 2.34M 209M | Sales 2025 * | 6.98M 6.52M 583M | Capitalization | 34.24M 32.02M 2.86B |
---|---|---|---|---|---|
Net income 2024 * | -32M -29.92M -2.67B | Net income 2025 * | -24M -22.44M -2B | EV / Sales 2024 * | 13.7 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.91 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.53% |
Latest transcript on Renalytix Plc
1 week | +6.15% | ||
Current month | +13.77% | ||
1 month | -22.13% | ||
3 months | -51.03% | ||
6 months | +29.25% | ||
Current year | +12.43% |
![Extreme 0.186](/images/extremecours_fleche.png)
![Extreme 0.155](/images/extremecours_fleche.png)
![Extreme 0.114](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 15/18/15 |
Howard Doran
PSD | President | 63 | 01/23/01 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 15/18/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 30/21/30 |
Chairman | 72 | 15/18/15 | |
James McCullough
FOU | Founder | 56 | 15/18/15 |
Date | Price | Change |
---|---|---|
21/24/21 | 0.19 | 0.00% |
20/24/20 | 0.19 | -0.52% |
19/24/19 | 0.191 | 0.00% |
18/24/18 | 0.191 | -10.75% |
17/24/17 | 0.214 | 0.00% |
Delayed Quote Börse Stuttgart, June 21, 2024 at 07:42 pm IST
More quotes![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.21% | 14.7B | |
-52.27% | 2.33B | |
+23.01% | 1.96B | |
-10.06% | 1.52B | |
+21.24% | 1.24B | |
-23.46% | 904M | |
+1.33% | 784M | |
-34.13% | 750M | |
+23.58% | 597M |
- Stock Market
- Equities
- RENX Stock
- 2O9 Stock